This inventor holds 2 USPTO granted patents. Top assignee: Apotex Inc.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Siva Ramarao Kakani: Innovator in Pharmaceutical Chemistry
Introduction
Siva Ramarao Kakani is a notable inventor based in Brantford, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of zuclomiphene citrate. With a total of 2 patents, Kakani's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Kakani's latest patents include innovative formulations that enhance the efficacy of zuclomiphene citrate. The first patent focuses on the crystalline forms of zuclomiphene citrate, specifically Forms APO-I, APO-II, APO-III, and APO-IV. These forms are designed to be used in pharmaceutical compositions aimed at treating disorders such as osteoporosis, bone fractures, loss of bone mineral density (BMD), and hot flashes. The second patent introduces zuclomiphene salts, including the zuclomiphene binaphthyl hydrogen phosphate salt and the zuclomiphene oxalate salt, along with their crystalline forms and preparation processes.
Career Highlights
Kakani is currently associated with Apotex Inc., a leading pharmaceutical company known for its commitment to innovation and quality. His work at Apotex has allowed him to focus on developing advanced pharmaceutical solutions that address critical health issues.
Collaborations
Kakani has collaborated with esteemed colleagues such as Fabio E S Souza and Mohammed Abdul Raheem. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Siva Ramarao Kakani's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
